Patent · US Active

Anti-FcRH5 antibodies and immunoconjugates and methods of use

US8617559B2 · kind B2 · utility

14Cited by
16References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 20, 2012
Grant dateDec 31, 2013
Priority date
Expiry dateNov 20, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.